Delivery Order SPE2DB25D3201-SPE2DB26FNNXH
Award Date 11/6/25
Potential Completion Date 12/1/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Andexxa 200 mg vials, a critical reversal agent used in military and federal healthcare settings. The contract is valued at $6,931.53 with a firm fixed price structure and completion deadline of October 1, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Andexxa 200 mg vials, with a ceiling value of $17,344.30 and a firm fixed price structure. The delivery order is not set-aside and is scheduled for completion by May 15, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a competitively awarded transaction under the company's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Andexxa 200 mg vials, valued at $41,589.24 with a firm fixed price structure. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 umbrella value and extends through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,395.78 in Andexxa 200 mg vials, with a completion date of November 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. As a critical vendor in the federal medical supply chain,...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of ANDEXXA 200 MG VIALS. The delivery order, valued at $13,317.46, is a firm-fixed price contract with a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ANDEXXA 200 MG VIALS. The contract has a ceiling value of $26,016.45 and an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation. The contract, valued at $7,570.17, is for the supply of ANDEXXA 200 MG VIALS, a specialty pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) with a total potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,726.12 firm-fixed-price contract is for the supply of 4,567,955,833 units of the medication ANDEXXA 200 MG VIALS. The award has an ultimate completion date of May 8, 2025 and was made on April 17, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,931.53, is for the delivery of ANDEXXA 200 MG VIALS and has an ultimate completion date of April 2, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency (DLA) has awarded a $6,658.73 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the delivery of ANDEXXA 200 MG VIALS and has an ultimate completion date of May 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00...